Patents by Inventor Mutsa Tatenda MADONDO

Mutsa Tatenda MADONDO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predicting responders to cyclophosphamide therapy
    Patent number: 11573234
    Abstract: The present disclosure is based on detecting CC chemokine receptor 4 (CCR4) expression on T effector cells to diagnostically or prophylactically predict subjects, in particular those with a gynaecological cancer who will respond to treatment with low dose cyclophosphamide.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: February 7, 2023
    Assignee: ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY
    Inventors: Magdalena Plebanski, Mutsa Tatenda Madondo
  • Predicting Responders to Cyclophosphamide Therapy
    Publication number: 20200158733
    Abstract: The present disclosure is based on detecting CC chemokine receptor 4 (CCR4) expression on T effector cells to diagnostically or prophylactically predict subjects, in particular those with a gynaecological cancer who will respond to treatment with low dose cyclophosphamide.
    Type: Application
    Filed: May 18, 2018
    Publication date: May 21, 2020
    Applicant: Royal Melbourne Institute of Technology
    Inventors: Magdalena PLEBANSKI, Mutsa Tatenda MADONDO